| EP3212629 - SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.08.2019 Database last updated on 08.04.2026 | |
| Former | The patent has been granted Status updated on 21.09.2018 | ||
| Former | Grant of patent is intended Status updated on 08.08.2018 | ||
| Former | Request for examination was made Status updated on 06.07.2018 | ||
| Former | Grant of patent is intended Status updated on 07.05.2018 | ||
| Former | Request for examination was made Status updated on 04.08.2017 | ||
| Former | The international publication has been made Status updated on 26.05.2017 | Most recent event Tooltip | 30.08.2019 | No opposition filed within time limit | published on 02.10.2019 [2019/40] | Applicant(s) | For all designated states Genoscience Pharma SAS 10, rue d'Iena 13006 Marseille / FR | [2017/36] | Inventor(s) | 01 /
BASSISSI, Firas 19, rue Pierre Laurent Appartement 104 13006 Marseille / FR | 02 /
BERET, Antoine 54, Chemin de Morgiou 13009 Marseille / FR | 03 /
BRUN, Sonia Résidence les Fleurs Appartement B201 115, rue Isaac Newton 13100 Aix-en-Provence / FR | 04 /
COURCAMBECK, Jérôme 50, Boulevard du Vaisseau Les Hauts de Mazargues D5 13009 Marseille / FR | 05 /
DUBRAY, Clarisse Le Belvédère Appartement B305 17, rue du Docteur Alfred Corlay 44800 Saint-Herblain / FR | 06 /
NICOLAS, Gregory 8, rue des Saules 35510 Cesson Sevigne / FR | 07 /
HALFON, Philippe 6, Allée du Château Parc Marveyre 13008 Marseille / FR | [2017/41] |
| Former [2017/36] | 01 /
BASSISSI, Firas 19, rue Pierre Laurent Appartement 104 13006 Marseille / FR | ||
| 02 /
BERET, Antoine 54, Chemin de Morgiou 13009 Marseille / FR | |||
| 03 /
BRUN, Sonia 160, rue Edmond Haley Résidence Le Clos de Médicis Appartement B205 La Duranne 13100 Aix-en-Provence / FR | |||
| 04 /
COURCAMBECK, Jérôme 50, Boulevard du Vaisseau Les Hauts de Mazargues D5 13009 Marseille / FR | |||
| 05 /
DUBRAY, Clarisse 51, Avenue du Pigonnet Résidence Jean Giono 13090 Aix-en-Provence / FR | |||
| 06 /
NICOLAS, Gregory 126, rue Augustin Aubert Entrée B 13009 Marseille / FR | |||
| 07 /
HALFON, Philippe 6, Allée du Château Parc Marveyre 13008 Marseille / FR | Representative(s) | Santarelli 7, rue de la République 13001 Marseille / FR | [2017/36] | Application number, filing date | 15837091.6 | 26.10.2015 | [2017/36] | WO2015IB02438 | Priority number, date | US201462073325P | 31.10.2014 Original published format: US 201462073325 P | [2017/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016067112 | Date: | 06.05.2016 | Language: | EN | [2016/18] | Type: | A1 Application with search report | No.: | EP3212629 | Date: | 06.09.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.05.2016 takes the place of the publication of the European patent application. | [2017/36] | Type: | B1 Patent specification | No.: | EP3212629 | Date: | 24.10.2018 | Language: | EN | [2018/43] | Search report(s) | International search report - published on: | EP | 06.05.2016 | Classification | IPC: | C07D401/04, A61K31/47, A61P35/00 | [2017/36] | CPC: |
C07D401/04 (EP,CN,IL,US);
A61K31/4545 (IL,US);
A61K31/506 (IL,US);
A61K9/1273 (IL,US);
A61K9/14 (IL,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/04 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P25/00 (EP);
A61P35/00 (EP,US);
A61P35/02 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/36] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | 11.05.2017 | Title | German: | SUBSTITUIERTE 2,4 DIAMINO-CHINOLIN ALS NEUE ANTIKREBSMITTEL | [2017/36] | English: | SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS | [2017/36] | French: | 2,4-DIAMINO-QUINOLÉINE SUBSTITUÉE SERVANT DE NOUVEAUX AGENTS ANTICANCÉREUX | [2017/36] | Entry into regional phase | 11.05.2017 | National basic fee paid | 11.05.2017 | Designation fee(s) paid | 11.05.2017 | Examination fee paid | Examination procedure | 11.05.2017 | Examination requested [2017/36] | 11.05.2017 | Date on which the examining division has become responsible | 10.11.2017 | Amendment by applicant (claims and/or description) | 08.05.2018 | Communication of intention to grant the patent | 27.06.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 09.08.2018 | Communication of intention to grant the patent | 12.09.2018 | Fee for grant paid | 12.09.2018 | Fee for publishing/printing paid | 12.09.2018 | Receipt of the translation of the claim(s) | Opposition(s) | 25.07.2019 | No opposition filed within time limit [2019/40] | Fees paid | Renewal fee | 27.09.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 24.10.2018 | SM | 24.10.2018 | [2019/37] |
| Former [2019/26] | AL | 24.10.2018 | Cited in | by applicant | GREVE, B. ET AL., CYTOMETRY A, 2012, pages 284 - 293 | LIU, S. ET AL., PLOS ONE, 2013, pages E81050 | RAN, D. ET AL., EXP. HEMATOL., 2009, pages 1423 - 1434 | CHEUNG, A. M., LEUKEMIA, 2007, pages 1423 - 1430 | PEARCE, D. J. ET AL., STEM CELLS, 2005, pages 752 - 760 | "Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems", 2014, WOLTERS KLUWER HEALTH | "Remington: The Science and Pratice of Pharmacy", 2012, PHARMACEUTICAL PRESS | "Prodrugs: Challenges and Rewards", 2007, SPRINGER | "Prodrugs and Targeted Delivery: Towards Better ADME Properties", 2011, WILEY-VCH | STORMS, R. W.; TRUJILLO, A. P.; SPRINGER, J. B.; SHAH, L.; COLVIN, O. M.; LUDEMAN, S. M.; SMITH, C.: "Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 96, no. 16, 1999, pages 9118 - 9123 |